HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Illés, Z. Articles by Kuchroo, V. K. Search for Related Content PubMed PubMed Citation Articles by Illés, Z. Articles by Kuchroo, V. K.

T Cell Tolerance Induced by Cross-Reactive TCR Ligands Can Be Broken by Superagonist Resulting in Anti-Inflammatory T Cell Cytokine Production¹

Center for Neurologic Diseases, Harvard Institute of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

Cross-reactive activation of potentially autoreactive T cells by high-affinity nonself ligands may be important in breaking self-tolerance in autoimmunity. In a mouse transgenic for a cross-reactive TCR, we have previously shown that a hyperstimulating altered peptide ligand, L144, induced unresponsiveness to the self peptide, proteolipid protein 139–151. In this study, we demonstrate that a superagonist ligand can break T cell tolerance induced by the lower affinity cognate Ag. T cells tolerant to the cognate ligand, Q144, responded to superagonist, L144, by proliferation and the production of mainly IL-4 and IL-10 in vitro. In contrast, T cells that were tolerized to the superagonist were unable to respond to any peptide that cross-reacted with the transgenic TCR. Low-dose immunization with the superagonist L144 was able to break tolerance to the cognate ligand in vivo and resulted in a blunted proliferative response with production of Th2 cytokines.

This article has been cited by other articles:

				L. M. Cortes, D. Avichezer, P. B. Silver, D. Luger, M. J. Mattapallil, C.-C. Chan, and R. R. Caspi Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells J. Leukoc. Biol., August 1, 2008; 84(2): 577 - 585. [Abstract] [Full Text] [PDF]

				H. A. Wasserman and B. D. Evavold Induction of Anergy by Antibody Blockade of TCR in Myelin Oligodendrocyte Glycoprotein-Specific Cells J. Immunol., June 1, 2008; 180(11): 7259 - 7264. [Abstract] [Full Text] [PDF]

				Z. Illes, H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background Int. Immunol., October 1, 2007; 19(10): 1235 - 1248. [Abstract] [Full Text] [PDF]

				M. L. Kemp, L. Wille, C. L. Lewis, L. B. Nicholson, and D. A. Lauffenburger Quantitative Network Signal Combinations Downstream of TCR Activation Can Predict IL-2 Production Response J. Immunol., April 15, 2007; 178(8): 4984 - 4992. [Abstract] [Full Text] [PDF]